Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - November 2014


Advances in Cell Based Assays

11 Nov 2014 - 12 Nov 2014 - London, UK



Bookmark and Share


SMi Group invites you to attend the market leading cell based event, Advances in Cell Based Assays, taking place on 11th & 12th November in Central London.

We have worked closely with an array of industry KOLs and scientific leaders to host a packed conference agenda for the 7th annual conference this autumn

Expand your scientific horizons as we ask the questions: 

  • How have recent advances in high throughput sample expression techniques opened up new possibilities for primary HTS within the biologics industry? 
  • What are the current challenges of bioassay method development and how can we validate these with reference to cell based assays and regulatory guidelines in drug development? 
  • What is the next generation of target identification and screening technologies? 
  • How easy is it to use adult stem cells in therapeutic applications, in vitro and in vivo paradigm?
  • How can we exploit gene editing in human cell lines to provide novel, isogenic assays? 
  • How are new technologies impacting the industry? 
  • 3D cell culture, how can this be used in oncology research? 
  • What is the next generation of cell based assays?

Key Speakers Include:

  • Steve Ludbrook, Group Leader, Biological Sciences UK, RD Platform Technology & Science, GSK
  • Beverley Isherwood, Team Leader High Content Biology, Innovative Medicines, AstraZeneca R&D
  • Dr Lesley Jenkinson, Scientist 1, Medimmune
  • Dr Farnaz Fallah-Arani, Group Leader, Pharmacology, UCB
  • Neil Carragher, PhD, Principal Investigator Drug Discovery, Edinburgh Cancer Research UK Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh
  • Niclas Nilsson, Head of Section, Lead Discovery, LEO Pharma
  • Dr Christa Burger, Principal Scientist, Cellular Pharmacology, Merck Serono
  • Dr Marianne Uteng, PhD, Head of Cellular Models & HCB Laboratory, Discovery and Investigative Safety (DIS), Novartis
  • Anker Jon Hansen, Principal Scientist, Novo Nordisk
  • Daniel Nolan, Director of Research, Angiocrine Bioscience

For further details and to download a copy of the PDF,  visit http://www.smi-online.co.uk/goto/2014cellbasedassay36.asp 

Alternatively contact Fateja Begum on +44 (0)20 7827 6184 or email fbegum@smi-online.co.uk



Further information
Scientific News
Promising Class of New Cancer Drugs Cause Memory Loss in Mice
New findings from The Rockefeller University suggest that the original version of BET inhibitors causes molecular changes in mouse neurons, and can lead to memory loss in mice that receive it.
Electrical Control of Cancer Cells
Research led by scientists at The University of Texas Health Science Center at Houston (UTHealth) has revealed a new electrical mechanism that can control these switches.
Signature of Microbiomes Linked to Schizophrenia
Studying microbiomes in throat may help identify causes and treatments of brain disorder.
Inflammation Linked to Colon Cancer Metastasis
A new Arizona State University research study led by Biodesign Institute executive director Raymond DuBois has identified for the first time the details of how inflammation triggers colon cancer cells to spread to other organs, or metastasize.
Structural Discoveries Could Aid in Better Drug Design
Scientists have uncovered the structural details of how some proteins interact to turn two different signals into a single integrated output.
Determining the Age of Fingerprints
Watch the imprint of a tire track in soft mud, and it will slowly blur, the ridges of the pattern gradually flowing into the valleys. Researchers have tested the theory that a similar effect could be used to give forensic scientists a way to date fingerprints.
Genetic Overlapping in Multiple Autoimmune Diseases May Suggest Common Therapies
CHOP genomics expert leads analysis of genetic architecture, with eye on repurposing existing drugs.
Surprising Mechanism Behind Antibiotic-Resistant Bacteria Uncovered
Now, scientists at TSRI have discovered that the important human pathogen Staphylococcus aureus, develops resistance to this drug by “switching on” a previously uncharacterized set of genes.
Tissue Bank Pays Dividends for Brain Cancer Research
Checking what’s in the bank – the Brisbane Breast Bank, that is – has paid dividends for UQ cancer researchers.
Researchers Publish Landmark “Basket Study”
Researchers from Memorial Sloan Kettering Cancer Center (MSK) have announced results from the first published basket study, a new form of clinical trial design that explores responses to drugs based on the specific mutations in patients’ tumors rather than where their cancer originated.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!